Minimal risk remains an open question

Am J Bioeth. 2011 Jun;11(6):25-7. doi: 10.1080/15265161.2011.568579.

Authors

Ariella Binik¹, Charles Weijer, Mark Sheehan

Affiliation

¹ University of Western Ontario, Department of Philosophy, Rotman Institute of Philosophy, Stevenson Building, London, Ontario, N68 5B8, Canada. [email protected]

PMID: 21678212
DOI: 10.1080/15265161.2011.568579

No abstract available

Publication types

Comment

MeSH terms

AIDS Vaccines / administration & dosage*
AIDS Vaccines / adverse effects
Adolescent
Clinical Trials as Topic / ethics*
Clinical Trials as Topic / methods
Community-Based Participatory Research / ethics*
Community-Based Participatory Research / methods
HIV Infections / prevention & control*
Humans
Nontherapeutic Human Experimentation / ethics
Patient Selection / ethics*
Primary Prevention / ethics*
Primary Prevention / methods
Risk
Risk-Taking

Substances

AIDS Vaccines